BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Taysha Gene Therapies\, Inc. (TSHA) investor events
X-WR-CALNAME:Taysha Gene Therapies\, Inc. (TSHA) investor events
DESCRIPTION:Earnings calls and investor events for Taysha Gene Therapies\, 
 Inc. (TSHA)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Taysha Gene Therapies\,
  Inc. (TSHA)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:ceec63f7-25ba-4225-96f3-07ac66f79fa9@equibles.com
DTSTAMP:20260610T223054Z
DTSTART;VALUE=DATE:20260319
DTEND;VALUE=DATE:20260320
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Taysha Gene Therapies\, Inc. (TSHA) Earnings Call\, FY2025 Q4
DESCRIPTION:The start time has not been announced.\nWebcast: https://edge.m
 edia-server.com/mmc/p/wipkt6zn
URL:https://equibles.com/stocks/tsha/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:7c379e31-faf0-4dc7-a119-362b4e3d49d5@equibles.com
DTSTAMP:20260611T010614Z
DTSTART;VALUE=DATE:20260506
DTEND;VALUE=DATE:20260507
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Taysha Gene Therapies\, Inc. (TSHA) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.\nWebcast: https://edge.m
 edia-server.com/mmc/p/ktcotnjh
URL:https://equibles.com/stocks/tsha/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:b9ef0511-609f-48a1-b405-03e55b7cf6d2@equibles.com
DTSTAMP:20261117T150014Z
DTSTART:20260622T123000Z
DTEND:20260622T133000Z
SEQUENCE:27702014
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Taysha Gene Therapies\, Inc. (TSHA) Conference: TSHA-102 Rett Syndr
 ome Program Update Conference Call
DESCRIPTION:TSHA-102 Rett Syndrome Program Update Conference Call\nWebcast:
  https://edge.media-server.com/mmc/p/ffpbwn9i/
URL:https://equibles.com/stocks/tsha/events/b9ef0511-609f-48a1-b405-03e55b7
 cf6d2
END:VEVENT
BEGIN:VEVENT
UID:d2a7e0eb-1655-4aa1-a08d-9947f17237b3@equibles.com
DTSTAMP:20260808T215034Z
DTSTART;VALUE=DATE:20260811
DTEND;VALUE=DATE:20260812
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Taysha Gene Therapies\, Inc. (TSHA) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.\nWebcast: https://edge.m
 edia-server.com/mmc/p/ythq6a3r
URL:https://equibles.com/stocks/tsha/calls/2026-q2
END:VEVENT
BEGIN:VEVENT
UID:4cc1d09c-f0e8-4a84-b991-20befb02072d@equibles.com
DTSTAMP:20261112T161304Z
DTSTART:20261112T133000Z
DTEND:20261112T143000Z
SEQUENCE:27274384
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Taysha Gene Therapies\, Inc. (TSHA) Earnings Call\, FY2026 Q3
DESCRIPTION:Webcast: https://edge.media-server.com/mmc/p/ss25x89r
URL:https://equibles.com/stocks/tsha/calls/2026-q3
END:VEVENT
END:VCALENDAR
